Adverum Biotechnologies (NASDAQ:ADVM – Free Report) had its target price reduced by Royal Bank of Canada from $12.00 to $10.00 in a report released on Tuesday, Benzinga reports. They currently have a sector perform rating on the biotechnology company’s stock. Other equities research analysts have also recently issued research reports about the company. Truist Financial […]

StockNews.com cut shares of Select Medical (NYSE:SEM – Free Report) from a buy rating to a hold rating in a research note published on Tuesday. SEM has been the subject of several other reports. Benchmark restated a “buy” rating and issued a $48.00 price objective on shares of Select Medical in a research note on […]

Pediatrix Medical Group (NYSE:MD – Free Report) had its price target hoisted by Mizuho from $13.00 to $15.00 in a research report released on Monday, Benzinga reports. Mizuho currently has a neutral rating on the stock. A number of other equities analysts have also recently weighed in on the company. Truist Financial raised their price […]

Adverum Biotechnologies (NASDAQ:ADVM – Get Free Report) had its price target cut by analysts at Royal Bank of Canada from $12.00 to $10.00 in a research report issued on Tuesday, Benzinga reports. The firm presently has a “sector perform” rating on the biotechnology company’s stock. Royal Bank of Canada’s price target would suggest a potential […]